Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Trading Statement

7 Mar 2005 07:02

Plant Health Care PLC07 March 2005 Press Release For immediate release: 7 March 2005 Plant Health Care plc Trading Statement Plant Health Care plc ("PHC" or the "Company"), the leading supplier of naturalproducts for plants and soil, provides an update on current trading. Sales for the year ended 31 December 2004 for the US, PHC Mexico, PHCNetherlands and PHC Reclamation were in line with expectations. We had expectedthe UK operation to be achieving further sales into the Spanish market, whichwas already penetrated through sales of PHC's Liquid Organic Plant Food, and theopening of a Spanish office. However, the UK division was unable to accelerateits Spanish sales due to the slow response of the Spanish government in issuingthe business registration permit. Additionally, a key supplier was late ondelivery of products because of labeling issues during the key part of theseason and sales were missed. As a consequence, sales for this business unitwill be below target. The Spanish company has now been formed and awarded itstax number and labeling issues have been resolved. We also accelerated our distributor early order programme from the first quarterof 2005 into the fourth quarter of 2004. This change, which aligned the companywith standard industry practices in the US landscape market, neverthelesscontributed to a deterioration of percentage margins because of the pricing onlarge orders. It is anticipated that margins in 2005 will return to previouslevels due to already implemented price increases combined with the operatingefficiencies that will be realized by the new manufacturing plant. The Company has been evaluating the prospect of relocating its Pittsburghmanufacturing plant for some time. The Directors recently received notificationthat a potential tenant is willing to lease a significant portion of the spacewhich would allow PHC an economical exit from the property. The proceedsreceived from the AIM IPO allow PHC to sublet the current plant and take a onetime charge in 2004. Accordingly, the Board has decided to take advantage ofthis opportunity and relocate the Pittsburgh manufacturing plant to a newsignificantly lower cost site. Whilst there will be a one off restructuring andrelocation charge, the new manufacturing facility is expected to reduce rentalcosts by approximately 50% and realise operating efficiencies through bettermachinery layout and more advanced equipment. We estimate that payback on theinvestment by way of cost savings will be achieved in less then 2 years. The Company has decided to accelerate the entry of its Myconate seed coatingproduct, acquired from VAMTech in October 2004, into the European market and asa consequence incurred costs that were originally budgeted for 2005. On thestrength of the Myconate test results announced in early December, and theinterest for the product by some key European distributors, management electedto commission a study of key European corn and wheat growing regions to targetthe markets which will provide optimal entry points for the product's Europeanlaunch. This combined with the earlier than expected recruitment costs for aseed coating General Manager moved expenses into the fourth quarter of 2004rather than in 2005 as anticipated. The management also decided to accelerate the hiring of several other keyindividuals to drive the growth of the Company. A General Manager for the USoperation was added along with several sales people to extend coverage moreuniformly across the US. Whilst the Directors believe the relocation of the manufacturing facility andthe acceleration of the move of the seed coating business into Europe willgreatly benefit the business these moves, together with the other mattersreferred to above, will cause the losses in 2004 to be some $1,100,000 greaterthan previously expected. The underlying trends for the business are stronger than ever and, coupled withthe added coverage by the new sales hires, the Directors expect current growthto continue in the coming months and into the future. For further information please contact: Plant Health Care plc Tavistock CommunicationsJohn Brady, CEO Jeremy Carey/Katy PrattTel: 001 603 525 3702 Tel: 020 7920 3150Steve Whitcomb Email: kpratt@tavistock.co.ukTel: 001 412 826 5488 Notes to Editors About PHC Plant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 60 employees and has operations in theUS, Mexico, UK and the Netherlands with technical support in Austria. The Grouphas two principal operating subsidiaries in the US - PHC Inc (PA) and PHCReclamation. The Company listed on the AIM market of the London Stock Exchangein July 2004. PHC's products are aimed at the horticulture, agriculture, turf grass,commercial landscaping, forestry and land reclamation industries and are bothenvironmentally beneficial and on the whole more cost effective than syntheticchemical alternatives. Through the commercialisation of these products, PHC iscapitalising on current long-term trends toward natural systems and biologicalproducts for plant care and soil and water management uses. PHC Reclamation is an environmental and reclamation engineering consulting firmproviding cost effective, biologically based solutions for the reclamation andrestoration of lands disturbed by mining, construction and other activities. PHCReclamation was established in 1997 to exploit PHC's products and technology. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Apr 20227:00 amRNSHolding(s) in Company
19th Apr 20221:46 pmRNSNotice of results and investor presentation
11th Apr 202212:52 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNew Distribution agreement with Ager Agro
14th Mar 202212:49 pmRNSHolding(s) in Company
11th Mar 202212:19 pmRNSHolding(s) in Company
3rd Feb 202212:56 pmRNSHolding(s) in Company
1st Feb 20221:16 pmEQSPlant Health Care, plc
1st Feb 20227:00 amRNS2021 Trading Statement
31st Jan 20227:00 amRNSPHC949 product registration submitted to the EPA
17th Jan 20227:00 amRNSInvestor Presentation
15th Dec 20217:00 amRNSWilbur Ellis and Plant Health Care discussion
13th Dec 20217:00 amRNSCommercial scale manufacturer for Saori
30th Nov 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20216:03 pmRNSExercise of Options
22nd Sep 20217:00 amRNSNew agreement with Nutrien for Saori launch
22nd Sep 20217:00 amRNSInterim Report 30 June 2021
21st Sep 20214:41 pmRNSSecond Price Monitoring Extn
21st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSArgentina approves Harpin as a seed treatment
24th Aug 20217:00 amRNSInvestor Presentation
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:36 pmRNSPrice Monitoring Extension
9th Aug 20211:27 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSAdmission to the U.S. OTCQB Venture Market
27th Jul 20217:00 amRNSNew Distribution Agreement with Agrii UK
26th Jul 20217:00 amRNS2021 Half-Year Trading Statement
23rd Jul 20217:00 amRNSGrant of Options
22nd Jul 20217:00 amRNSInvestor Presentation
12th Jul 20214:40 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20212:33 pmRNSResult of AGM
14th Jun 20217:00 amRNSGreen Economy Mark awarded
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSInvestor Presentation
7th May 20213:50 pmRNSAnnual Report & Accounts and AGM Notice Published
30th Apr 20215:40 pmRNSHolding(s) in Company
23rd Apr 20217:00 amRNSResults for the year ended 31 December 2020
21st Apr 202111:58 amRNSHolding(s) in Company
8th Apr 20213:30 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
22nd Mar 20217:00 amRNSInvestor Presentation
18th Mar 20211:57 pmRNSResults of Placing and Subscription
18th Mar 20217:00 amRNSProposed Placing and Subscription
1st Mar 20217:00 amRNSSaori Trial Update
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.